NCT04416919

Brief Summary

The purpose of this study is to assess the safety and efficiency of an assembled modified mask in protecting health care workers against Coronavirus in case of any personal protective equipment shortage. At least 20 healthy participants will be recruited to try the modified mask. The modified masks will be made from masks that are already available as well as filters available in the pulmonary department at the Oklahoma City VA Health Care System

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 13, 2020

Completed
7 days until next milestone

Study Start

First participant enrolled

May 20, 2020

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2022

Completed
Last Updated

March 8, 2024

Status Verified

March 1, 2024

Enrollment Period

12 days

First QC Date

May 13, 2020

Last Update Submit

March 7, 2024

Conditions

Keywords

2019 novel coronavirus disease2019 novel coronavirus infectionCOVID-19 pandemicCOVID-19 virus diseaseCOVID19COVID-19 virus infectionN-95Respiratory protective devicesProtection from respiratory infectonSafetyEfficacyPandemic

Outcome Measures

Primary Outcomes (1)

  • Success Percentage

    Conduct a quantitative fit test and calculate the percentage of participants who pass the test.

    15 minutes

Secondary Outcomes (4)

  • End-tidal CO2 Variation. Description: mmHg.

    at 0 and 15 minutes

  • Oxygen Pulse Oximetry Variation. Description: mmHg.

    at 0 and 15 minutes.

  • Mask Visibility. Description: Likert Scale.

    15 minutes

  • Willingness of usage. Description: Likert Scale.

    after 15 minutes

Study Arms (1)

Assembled Mask

OTHER

Participant will be fitted with a full-face mask that covers the mouth and nose or a Whole face mask that covers the eyes, nose, and mouth depending on participant's preferences. The Fitted Mask will be attached to a bacterial/viral filter for fit testing. After completing the Fit test, the mask will be placed on the face for 15 minutes while the participant performs various activities to document the ability to tolerate the respirator. Participants oxygen and carbon dioxide level will be measured in the beginning and at the end of the 15 minutes. The individuals will be able to remove the Mask anytime if they experience significant discomfort or claustrophobia. At the end, the mask will be removed.

Other: Assembled mask

Interventions

Assembled masks consisting of 3 parts: A facemask (Respironics Performax Whole Face Mask or Hans Rudolph mask naso-oral mask) linked by a blue elbow ( RP Performax SE ELBOW) to a ventilator filter (Teleflex Bacterial/Viral filter 1605 or Iso-Gard HEPA light Filter 28022)

Assembled Mask

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. All individuals older than 18 years of age, and willing to participate in the study

You may not qualify if:

  • Individuals with known severe COPD/emphysema, Obesity Hypoventilation or hypercapnic condition
  • Individuals with allergy or reactions to latex or masks
  • Individuals reporting dyspnea or unable to breathe comfortably in these masks
  • Claustrophobic individuals
  • Inability to create a proper Seal while inhaling through a closed filter (See Below)
  • Individuals who cannot safely apply and remove these masks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oklahoma City VA Health Care System

Oklahoma City, Oklahoma, 73104, United States

Location

Related Publications (3)

  • Prevention CfDCa. Strategies for Optimizing the Supply of Facemasks: COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/face-masks.html

    BACKGROUND
  • van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17. No abstract available.

  • Qian Y, Willeke K, Grinshpun SA, Donnelly J, Coffey CC. Performance of N95 respirators: filtration efficiency for airborne microbial and inert particles. Am Ind Hyg Assoc J. 1998 Feb;59(2):128-32. doi: 10.1080/15428119891010389.

MeSH Terms

Conditions

Coronavirus InfectionsCOVID-19

Condition Hierarchy (Ancestors)

Coronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsVirus DiseasesInfectionsPneumonia, ViralPneumoniaRespiratory Tract InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Houssein Youness, MD

    University of Oklahoma HSC - OKC Veterans Affairs Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2020

First Posted

June 4, 2020

Study Start

May 20, 2020

Primary Completion

June 1, 2020

Study Completion

January 20, 2022

Last Updated

March 8, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations